Does TRASTUZUMAB-DTTB Cause Immune-mediated enterocolitis? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Immune-mediated enterocolitis have been filed in association with TRASTUZUMAB-DTTB. This represents 1.6% of all adverse event reports for TRASTUZUMAB-DTTB.
8
Reports of Immune-mediated enterocolitis with TRASTUZUMAB-DTTB
1.6%
of all TRASTUZUMAB-DTTB reports
0
Deaths
8
Hospitalizations
How Dangerous Is Immune-mediated enterocolitis From TRASTUZUMAB-DTTB?
Of the 8 reports, 8 (100.0%) required hospitalization.
Is Immune-mediated enterocolitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRASTUZUMAB-DTTB. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does TRASTUZUMAB-DTTB Cause?
Diarrhoea (150)
Product use in unapproved indication (89)
Nausea (66)
Pyrexia (65)
Off label use (63)
Anaemia (61)
Vomiting (46)
Hypokalaemia (43)
Chills (40)
Dyspnoea (37)
What Other Drugs Cause Immune-mediated enterocolitis?
NIVOLUMAB (1,289)
IPILIMUMAB (988)
PEMBROLIZUMAB (858)
CARBOPLATIN (307)
PACLITAXEL (188)
DURVALUMAB (165)
ATEZOLIZUMAB (156)
LENVATINIB (143)
PEMETREXED (129)
BEVACIZUMAB (92)
Which TRASTUZUMAB-DTTB Alternatives Have Lower Immune-mediated enterocolitis Risk?
TRASTUZUMAB-DTTB vs TRASTUZUMAB EMTANSINE
TRASTUZUMAB-DTTB vs TRASTUZUMAB-PKRB
TRASTUZUMAB-DTTB vs TRASTUZUMAB-QYYP
TRASTUZUMAB-DTTB vs TRAVOPROST
TRASTUZUMAB-DTTB vs TRAZODONE